作者
Sergey Moiseev,N. Bulanov,Matija Crnogorac,Haner Direşkeneli,Kres̆imir Gales̃ić,Ümmügülsüm Gazel,Duvuru Geetha,Loı̈c Guillevin,Zdenka Hrušková,Mark A. Little,Lorraine O’Neill,Egor Makarov,Stephen P. McAdoo,Aladdin J Mohammad,Sarah M. Moran,П. В. Новиков,Charles D. Pusey,Chinar Rahmattulla,Veronika Satrapová,Joana Silva,А. Yu. Suvorov,Vladimír Tesař,Benjamin Terrier,Peter Willeit,Ming‐Hui Zhao,Andreas Kronbichler,David Jayne
摘要
To investigate the occurrence of cardiovascular events (CVEs) in a large cohort of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) across the European Union, China, Turkey, Russia, the United Kingdom, and the USA.Patients with a definite diagnosis of AAV who were followed for ≥ 3 months and had sufficient documentation were included. Data on myocardial infarction (MI) and stroke were collected retrospectively from tertiary vasculitis centers. Univariate and multivariate Cox regression models were used to estimate hazard ratios (HRs) and 95% CIs.Over a median follow-up of 62.0 months (IQR 22.6-100.0), CVEs (mostly MIs) occurred in 245 (10.7%) of 2286 patients with AAV, with a higher frequency in China and the UK. On multivariate regression analysis, older age (55-64.9 yrs, HR 2.93, 95% CI 1.99-4.31), smoking (HR 1.98, 95% CI 1.48-2.64), Chinese origin (HR 4.24, 95% CI 3.07-5.85), and pulmonary (HR 1.50, 95% CI 1.09-2.06) and kidney (HR 3.02, 95% CI 2.08-4.37) involvement were independent variables associated with a higher occurrence of CVEs.We showed that geographic region and both traditional and disease-specific (kidney involvement in particular) factors were independently associated with CVEs. Proper assessment and management of modifiable cardiovascular (CV) risk factors are essential for prevention of CV morbidity in patients with AAV.